NETWise

Episode 4: Nuclear Medicine for NETs: What is PRRT?


Listen Later

Treating NETs with Nuclear Medicine

This episode of NETRF’s NETWise podcast discusses Peptide Receptor Radionuclide Therapy (PRRT) a targeted form of radiotherapy approved in the U.S. in 2018. Listen in as NET experts like Josh Mailman, Drs. George Fisher, Thor Halfdanarson, Ed Wolin, Richard Baum, and others explain what it is, how it works, and who is most likely to benefit from PRRT. This therapy relies on a tumor’s expression of somatostatin receptors. We explain what they are and how to know if you have them.

Then, we’ll take an objective look at the success rates for this therapy. What does research, like the NETTER-1 study, tell us about outcomes for this form of treatment? To give you information about both the pros and cons of PRRT, we will also discuss the potential side effects, from mild to serious. To give you a sense of what it is like to undergo PRRT, we’ll talk with multiple patients about their experience with the procedure itself, as well as the radiation safety precautions patients should take immediately following treatment. Finally, we look to the future asking Drs. Rod Hicks and Tom Hope to explain some of the new therapeutic directions PRRT is taking.

Use our episode infographics to get a visual picture of some of the things we have discussed.

PRRT for NETs. This handout explains how radioactive drugs are able to target NET cells with radioactivity using PRRT.

Download PDF

What is PRRT? A quick guide to answer your most basic questions about the pros and cons of PRRT.  What are the benefits of PRRT? What are the potential side effects of PRRT?  Who can be treated with PRRT? 

Download PDF
Download a transcript of this episode
Mentioned in this Episode:

Nuclear Medicine Treatments

Gallium-68 Dotatate PET/CT Scan

Search for PRRT treatment Centers Near You

What’s Next in PRRT Treatment

VIDEO: How PRRT Works and Who Benefits – Dr. Blase Polite, University of Chicago

VIDEO: What to Expect During PRRT Treatment – Karen Ohara, Rush University Medical Center

VIDEO: How PRRT Can Improve Care for NET Patients

VIDEO: Combining PRRT with Targeted Therapy

VIDEO: Tb-161: Exploring a New Radionuclide for PRRT

Additional NET Research Foundation Resources:

Request a mailed copy of our Neuroendocrine Cancer Guide

Information and Resources for the Newly Diagnosed

NETRF YouTube Channel

The post Episode 4: Nuclear Medicine for NETs: What is PRRT? appeared first on NETRF.

...more
View all episodesView all episodes
Download on the App Store

NETWiseBy Neuroendocrine Tumor Research Foundation (NETRF)

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

43 ratings


More shows like NETWise

View all
Fresh Air by NPR

Fresh Air

38,163 Listeners

The Moth by The Moth

The Moth

27,270 Listeners

The Rachel Maddow Show by Rachel Maddow, MSNBC

The Rachel Maddow Show

37,164 Listeners

The Daily by The New York Times

The Daily

111,112 Listeners

Up First from NPR by NPR

Up First from NPR

55,946 Listeners

The Daily Show: Ears Edition by iHeartPodcasts and Paramount Podcasts

The Daily Show: Ears Edition

14,197 Listeners

Neuroendocrine Expert Talks by Ipsen

Neuroendocrine Expert Talks

9 Listeners

The Dose by CBC

The Dose

84 Listeners

NETs Get Real with NCAN by Neuroendocrine Cancer Awareness Network

NETs Get Real with NCAN

6 Listeners

SmartLess by Jason Bateman, Sean Hayes, Will Arnett

SmartLess

57,909 Listeners

The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts by Neuroendocrine Cancer Foundation

The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts

10 Listeners

The Weekly Show with Jon Stewart by Comedy Central

The Weekly Show with Jon Stewart

10,256 Listeners

Offline with Jon Favreau by Crooked Media

Offline with Jon Favreau

2,211 Listeners

The Mel Robbins Podcast by Mel Robbins

The Mel Robbins Podcast

20,755 Listeners

The Oprah Podcast by Harpo

The Oprah Podcast

1,434 Listeners